Chief Financial Officer and Chief Operating Officer · ASSEMBLY BIOSCIENCES, INC. (ASMB)

Graham Cooper

FY2018 is the first fiscal year CompBrief holds for Graham Cooper as a named executive officer of ASSEMBLY BIOSCIENCES; the record below is that year, complete. Every figure below is printed as the company filed it and cited to the filing it came from.

Total disclosed compensation, FY2018

$11,780,248

Salary $346,266Stock awards $2,419,000

1st of 6 named executive officers at Assembly Biosciences by FY2018 total.

6 named officers on file for ASSEMBLY BIOSCIENCES, FY2018

Graham Cooper’s pay file — $29

  • 1 fiscal year of pay, line by line
  • 2 equity grants, each cited to its filing
  • ASMB’s disclosed peer group of 18 companies

A PDF and a CSV sent to your email. Every row is cited to its filing.

One-time report. No refunds.

See an example →

Velarion Intel · free for 3 days · no card

See how ASSEMBLY BIOSCIENCES’s whole pay program stands against its peers

  • ASSEMBLY BIOSCIENCES’s company dashboard and its AI-written, board-ready brief, every figure cited to the filing
  • Peer-group intelligence, custom peer reruns and governance screens
  • Every other company we cover, with alerts when they file
Start my free trial on ASMB→

No card. Nothing is charged, and the trial ends on its own.

Compensation figures as of the proxy filed April 4, 2019 (DEF 14A).

Free

Get Graham Cooper’s pay history as a PDF, right here and by email

The PDF adds what this page leaves out: up to 10 years of pay, a peer comparison, and the board on one page. Two emails at most, nothing else.

Graham Cooper compensation by year

ASSEMBLY BIOSCIENCES Summary Compensation Table · the one fiscal year held
In US dollars, as ASSEMBLY BIOSCIENCES reports it. Most recent year shaded. Totals are the company’s disclosed totals.
ComponentFY2018
Salary$346,266
Bonus$0
Stock awards$2,419,000
Option awards$8,853,732
Non-equity incentive$157,200
Pension and deferred compensation$0
All other$4,050
Total$11,780,248

Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: ASSEMBLY BIOSCIENCES, INC. DEF 14A filed April 4, 2019, accession 0001144204-19-018190, and prior-year filings. Open the filing on EDGAR.

How this page was built: the ASSEMBLY BIOSCIENCES, INC. filed document, accession 0001144204-19-018190. Every figure is read from that document and cited to the page and table it appears in. Filed April 4, 2019.

Equity holdings

unvested awards at FY2018 year-end
TypeUnvested unitsValue at year-endExercise price
RSU100,000$2,262,000—
Option220,000—$57.53

Per the Outstanding Equity Awards at Fiscal Year-End table in ASSEMBLY BIOSCIENCES, INC.'s FY2018 proxy; value at the fiscal year-end close, as the company printed it.

ASSEMBLY BIOSCIENCES’s named executive officers, FY2018

as the company reported each
Named executive officerRoleFY2018 total
Graham Cooper · this pageChief Financial Officer and Chief Operating Officer$11,780,248
David BarrettFormer Chief Financial Officer and Chief Operating Officer$5,324,225
Derek SmallPresident and Chief Executive Officer$4,746,040
Jacqueline PapkoffSenior Vice President, Chief Scientific Officer Microbiome$4,510,203
Richard ColonnoExecutive Vice President and Chief Scientific Officer of Virology Operations$2,909,439
Uri LopatinChief Medical Officer$1,499,187

The full ASSEMBLY BIOSCIENCES compensation record

free company brief

This page is one person within ASSEMBLY BIOSCIENCES's record. The company brief lists every named executive, each linking to their own page.

Peer companies

named in the ASSEMBLY BIOSCIENCES proxy · each links to its own free brief

Compensation, the day it’s disclosed

The CompBrief Daily Digest lists the newest executive and director compensation disclosures as companies file them.

How this record is built

Every figure on this page is one figure from a public SEC filing, printed as the filing states it and cited to the document. Compensation totals are ASSEMBLY BIOSCIENCES's own disclosed totals, not summed by Velarion. Insider transactions are read from Form 4 filings and cover every line filed since the most recent proxy. Nothing is estimated by Velarion; where the company does not disclose a value the cell reads "—", and a section appears only where the company discloses the data. Corrections: records@velarion.ai.

Graham Cooper's compensation dossier · One-time report. No refunds.